- 1 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 71 (1) , 17-23
Abstract
Recent evidence from HIV vaccine trials in humans and non-human primates suggests that nonneutralizing antibody functions, such as antibody-dependent cellular cytotoxicity (ADCC), are an important component of vaccine-mediated protection. Whether anti-HIV ADCC antibodies are present in seminal fluid, however, is not known. We assessed whether anti-HIV antibodies within seminal plasma mediate ADCC and activate natural killer (NK) cells. Using matched blood and seminal plasma samples, we detected anti-HIV IgG within samples from all 11 HIV-infected donors. Furthermore, anti-HIV antibodies within the seminal plasma triggered detectable ADCC in 9 of 11 donors and activated NK cells in 6 of 11 donors. The ability of seminal plasma-derived IgG to activate NK cells in an anti-HIV antibody-dependent manner was enhanced when IgG were enriched and other seminal plasma components were removed. These observations have relevance for understanding natural immunity to HIV infection and provide assistance with HIV vaccine design.Keywords
This publication has 24 references indexed in Scilit:
- HIV-1 Genital Shedding in HIV-Infected Patients Randomized to Second-Line Lopinavir/Ritonavir Monotherapy versus Tenofovir/Lamivudine/Lopinavir/ RitonavirAntiviral Therapy, 2013
- ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 ChallengePLOS Pathogens, 2012
- HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral LoadsPLOS Pathogens, 2012
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoireAIDS, 2011
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersAIDS, 2009
- Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populationsAIDS, 2004
- Presence of HIV-1 Neutralizing IgA Antibodies in Primary HIV-1 Infected PatientsScandinavian Journal of Infectious Diseases, 2004
- Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120Nature Medicine, 2003
- Sustained Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in SIV-Infected Macaques Correlates with Delayed Progression to AIDSAIDS Research and Human Retroviruses, 2002